This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (89)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

A Propensity Analysis

Patricia A. Gum, MD; Maran Thamilarasan, MD; Junko Watanabe, MD; Eugene H. Blackstone, MD; Michael S. Lauer, MD

JAMA. 2001;286:1187-1194.

Context  Although aspirin has been shown to reduce cardiovascular morbidity and short-term mortality following acute myocardial infarction, the association between its use and long-term all-cause mortality has not been well defined.

Objectives  To determine whether aspirin is associated with a mortality benefit in stable patients with known or suspected coronary disease and to identify patient characteristics that predict the maximum absolute mortality benefit from aspirin.

Design and Setting  Prospective, nonrandomized, observational cohort study conducted between 1990 and 1998 at an academic medical institution, with a median follow-up of 3.1 years.

Patients  Of 6174 consecutive adults undergoing stress echocardiography for evaluation of known or suspected coronary disease, 2310 (37%) were taking aspirin. Patients with significant valvular disease or documented contraindication to aspirin use, including peptic ulcer disease, renal insufficiency, and use of nonsteroidal anti-inflammatory drugs, were excluded.

Main Outcome Measure  All-cause mortality according to aspirin use.

Results  During 3.1 years of follow-up, 276 patients (4.5%) died. In a simple univariable analysis, there was no association between aspirin use and mortality (4.5% vs 4.5%). However, after adjustment for age, sex, standard cardiovascular risk factors, use of other medications, coronary disease history, ejection fraction, exercise capacity, heart rate recovery, and echocardiographic ischemia, aspirin use was associated with reduced mortality (hazard ratio [HR], 0.67; 95% confidence interval [CI], 0.51-0.87; P = .002). In further analysis using matching by propensity score, 1351 patients who were taking aspirin were at lower risk for death than 1351 patients not using aspirin (4% vs 8%, respectively; HR, 0.53 ; 95% CI, 0.38-0.74; P = .002). After adjusting for the propensity for using aspirin, as well as other possible confounders and interactions, aspirin use remained associated with a lower risk for death (adjusted HR, 0.56; 95% CI, 0.40-0.78; P<.001). The patient characteristics associated with the most aspirin-related reductions in mortality were older age, known coronary artery disease, and impaired exercise capacity.

Conclusion  Aspirin use among patients undergoing stress echocardiography was independently associated with reduced long-term all-cause mortality, particularly among older patients, those with known coronary artery disease, and those with impaired exercise capacity.

Author Affiliations: Departments of Cardiology (Drs Gum, Thamilarasan, Watanabe, and Lauer), Thoracic and Cardiovascular Surgery (Dr Blackstone), and Biostatistics and Epidemiology (Dr Blackstone), Cleveland Clinic Foundation, Cleveland, Ohio.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

How Do Observational Studies Expand the Evidence Base for Therapy?
Martha J. Radford and JoAnne M. Foody
JAMA. 2001;286(10):1228-1230.
EXTRACT | FULL TEXT  

September 12, 2001
JAMA. 2001;286(10):1249-1250.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan et al.
JAMA 2009;302:649-658.
ABSTRACT | FULL TEXT  

Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease
Muir et al.
Heart 2009;95:1225-1229.
ABSTRACT | FULL TEXT  

Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease: The Women's Health Initiative Observational Study
Berger et al.
Circ Cardiovasc Qual Outcomes 2009;2:78-87.
ABSTRACT | FULL TEXT  

Comparison of Early Surgery Versus Conventional Treatment in Asymptomatic Severe Mitral Regurgitation
Kang et al.
Circulation 2009;119:797-804.
ABSTRACT | FULL TEXT  

Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?
Trojano
Neurology 2007;69:1478-1479.
FULL TEXT  

Association of atheroma as assessed by intraoperative transoesophageal echocardiography with long-term mortality in patients undergoing cardiac surgery
Thambidorai et al.
Eur Heart J 2007;0:ehm180v1-8.
ABSTRACT | FULL TEXT  

A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure
Ahmed et al.
Eur Heart J 2007;28:1334-1343.
ABSTRACT | FULL TEXT  

Clinical Aspects of Platelet Inhibitors and Thrombus Formation
Meadows and Bhatt
Circ. Res. 2007;100:1261-1275.
ABSTRACT | FULL TEXT  

Long-term Aspirin Use and Mortality in Women
Chan et al.
Arch Intern Med 2007;167:562-572.
ABSTRACT | FULL TEXT  

The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFN{beta} exposure in multiple sclerosis
Trojano et al.
Mult Scler 2006;12:578-585.
ABSTRACT  

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods
Ahmed et al.
Eur Heart J 2006;27:1431-1439.
ABSTRACT | FULL TEXT  

Myocardial Viability Testing and the Effect of Early Intervention in Patients With Advanced Left Ventricular Systolic Dysfunction
Tarakji et al.
Circulation 2006;113:230-237.
ABSTRACT | FULL TEXT  

Prognostic significance of dyspnea in patients referred for cardiac stress testing.
Abidov et al.
NEJM 2005;353:1889-1898.
ABSTRACT | FULL TEXT  

Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease
Maree et al.
J Am Coll Cardiol 2005;46:1258-1263.
ABSTRACT | FULL TEXT  

Use of the Pulmonary Artery Catheter Is Not Associated With Worse Outcome in the ICU
Sakr et al.
Chest 2005;128:2722-2731.
ABSTRACT | FULL TEXT  

In-Hospital Mortality in Patients With Acute Decompensated Heart Failure Requiring Intravenous Vasoactive Medications: An Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE)
Abraham et al.
J Am Coll Cardiol 2005;46:57-64.
ABSTRACT | FULL TEXT  

In Search of Fewer Independent Risk Factors
Brotman et al.
Arch Intern Med 2005;165:138-145.
ABSTRACT | FULL TEXT  

Women and Heart Disease: The Role of Diabetes and Hyperglycemia
Barrett-Connor et al.
Arch Intern Med 2004;164:934-942.
ABSTRACT | FULL TEXT  

Impact of Valve Surgery on 6-Month Mortality in Adults With Complicated, Left-Sided Native Valve Endocarditis: A Propensity Analysis
Vikram et al.
JAMA 2003;290:3207-3214.
ABSTRACT | FULL TEXT  

Is it gender, methodology, or something else?
Koch et al.
J. Thorac. Cardiovasc. Surg. 2003;126:932-935.
FULL TEXT  

Exercise Capacity: The Prognostic Variable That Doesn't Get Enough Respect
Mark and Lauer
Circulation 2003;108:1534-1536.
FULL TEXT  

Effect of preoperative aspirin use in off-pump coronary artery bypass operations
Srinivasan et al.
Ann. Thorac. Surg. 2003;76:41-45.
ABSTRACT | FULL TEXT  

Aspirin and Clopidogrel in Acute Coronary Syndromes: Therapeutic Insights From the CURE Study
Jneid et al.
Arch Intern Med 2003;163:1145-1153.
ABSTRACT | FULL TEXT  

Complicated Left-Sided Native Valve Endocarditis in Adults: Risk Classification for Mortality
Hasbun et al.
JAMA 2003;289:1933-1940.
ABSTRACT | FULL TEXT  

Frequent Ventricular Ectopy after Exercise as a Predictor of Death
Frolkis et al.
NEJM 2003;348:781-790.
ABSTRACT | FULL TEXT  

The effect of pneumonia on mortality among patients hospitalized for acute stroke
Katzan et al.
Neurology 2003;60:620-625.
ABSTRACT | FULL TEXT  

Is Metabolic Syndrome X an Inflammatory Condition?
Das
Exp. Biol. Med. 2002;227:989-997.
ABSTRACT | FULL TEXT  

Resolvins: A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals
Serhan et al.
JEM 2002;196:1025-1037.
ABSTRACT | FULL TEXT  

Effectiveness of Adjuvant Fluorouracil in Clinical Practice: A Population-Based Cohort Study of Elderly Patients With Stage III Colon Cancer
Iwashyna and Lamont
JCO 2002;20:3992-3998.
ABSTRACT | FULL TEXT  

Anemia and Blood Transfusion in Critically Ill Patients
Vincent et al.
JAMA 2002;288:1499-1507.
ABSTRACT | FULL TEXT  

Comparing Mortality of Elderly Patients on Hemodialysis versus Peritoneal Dialysis: A Propensity Score Approach
Winkelmayer et al.
J. Am. Soc. Nephrol. 2002;13:2353-2362.
ABSTRACT | FULL TEXT  

Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease
Gaspoz et al.
NEJM 2002;346:1800-1806.
ABSTRACT | FULL TEXT  

Aspirin for Primary Prevention of Coronary Events
Lauer
NEJM 2002;346:1468-1474.
FULL TEXT  

Aspirin Use and All-Cause Mortality
JWatch Gastroenterology 2001;2001:10-10.
FULL TEXT  

Aspirin Beneficial for Patients with Impaired Exercise Capacity
Journal Watch Cardiology 2001;2001:6-6.
FULL TEXT  

Aspirin Use and All-Cause Mortality
JWatch General 2001;2001:2-2.
FULL TEXT  

How Do Observational Studies Expand the Evidence Base for Therapy?
Radford and Foody
JAMA 2001;286:1228-1230.
FULL TEXT